AI English summary of an SEC filing — figures as filed
The company said it declared a dividend of $0.432 per share for Q3 2024, payable on May 22, 2024. The press release said the Board of Directors declared the dividend.
Key points
AI summaryThe company said it declared a dividend of $0.432 per share for Q3 2024, payable on May 22, 2024. The press release said the Board of Directors declared the dividend.
The company said the dividend will be paid on September 4, 2024 to holders of record of its common stock as of the close of business on July 18, 2024.
The company said in its press release that Zoetis generated revenue of $8.5 billion in 2023, with approximately 14,100 employees, and that it operates in more than 100 countries with its medicines, vaccines, diagnostics and other products and technologies.
The company said the information in Item 7.01 and Exhibit 99.1 (press release dated May 22, 2024) shall not be deemed "filed" under the Securities Exchange Act of 1934.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Zoetis Declares Q3 2024 Dividend
The company said it declared a dividend of $0.432 per share for Q3 2024, payable on May 22, 2024. The press release said the Board of Directors declared the dividend.
Source · Based on the filing body and exhibits
Dividend Payment and Record Date
The company said the dividend will be paid on September 4, 2024 to holders of record of its common stock as of the close of business on July 18, 2024.
Source · Based on the filing body and exhibits
Company Overview in the Press Release
The company said in its press release that Zoetis generated revenue of $8.5 billion in 2023, with approximately 14,100 employees, and that it operates in more than 100 countries with its medicines, vaccines, diagnostics and other products and technologies.
Source · Based on the filing body and exhibits
Item 7.01 Disclosure and Attached Press Release
The company said the information in Item 7.01 and Exhibit 99.1 (press release dated May 22, 2024) shall not be deemed "filed" under the Securities Exchange Act of 1934.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…